Z42.1 is a valid billable ICD-10 diagnosis code for Encounter for breast reconstruction following mastectomy . It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022 .
| ICD-10 from 2011 - 2016 Z85.3 is a billable ICD code used to specify a diagnosis of personal history of malignant neoplasm of breast. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
ICD-10-CM Diagnosis Code Z42.1 [convert to ICD-9-CM] Encounter for breast reconstruction following mastectomy ICD-10-CM Diagnosis Code Z90.13 [convert to ICD-9-CM] Acquired absence of bilateral breasts and nipples
The ICD-10-CM code Z90.12 might also be used to specify conditions or terms like history of excision of left nipple, history of left mastectomy, history of mastectomy, history of mastectomy, history of mastectomy, history of prophylactic mastectomy, etc.
ICD-10 code Z90. 12 for Acquired absence of left breast and nipple is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
"Z90. 11 - Acquired Absence of Right Breast and Nipple." ICD-10-CM, 10th ed., Centers for Medicare and Medicaid Services and the National Center for Health Statistics, 2018.
Excision of Bilateral Breast, Open Approach ICD-10-PCS 0HBV0ZZ is a specific/billable code that can be used to indicate a procedure.
Acquired absence of left breast and nipple The 2022 edition of ICD-10-CM Z90. 12 became effective on October 1, 2021. This is the American ICD-10-CM version of Z90. 12 - other international versions of ICD-10 Z90.
Report code 19303, Mastectomy, simple, complete, for the mastectomy.
Breast Cancer ICD-10 Code Reference SheetPERSONAL OR FAMILY HISTORY*Z85.3Personal history of malignant neoplasm of breastZ80.3Family history of malignant neoplasm of breast
For example, if you are billing for a bilateral mastectomy, you would report CPT code 19303 (Mastectomy, simple, complete) with the modifier.
The breast surgery Current Procedural Terminology (CPT) codes were developed when axillary dissection was standard therapy for breast cancer. Modified radical mastectomy is coded 19307; lumpectomy with axillary dissection is coded 19302.
When both axillary lymph nodes and the internal mammary lymph nodes are taken during this operative session, the pectoralis major and minor can be spared. If the physician performs this procedure (also known as the Urban-type mastectomy), report 19306.
Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
If you have early invasive or locally advanced breast cancer, your doctor will usually recommend surgery right away. For early cancers there is the option of lumpectomy, also called breast-conserving surgery. In the case of locally advanced breast cancer, which is higher risk, a mastectomy is usually recommended.
11.
CPT 19380 is used when a revision is made to an already reconstructed breast that includes significant removal of tissue; re-ad- vancement and/or re-inset of flaps in autol- ogous reconstruction; or significant capsular revisions combined with soft-tissue excision in implant-based reconstruction.
Definition: Tumors or cancer of the human BREAST.
FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)
Modified radical mastectomy - removal of the breast, most of the lymph nodes under the arm, and often the lining over the chest muscles
Many women have breast reconstruction to rebuild the breast after a mastectomy. Sometimes mastectomy is done to prevent breast cancer. Only high-risk patients have this type of surgery.
Valid for Submission. Z90.12 is a billable diagnosis code used to specify a medical diagnosis of acquired absence of left breast and nipple. The code Z90.12 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
Sometimes mastectomy is done to prevent breast cancer. Only high-risk patients have this type of surgery.
Mastectomy. A mastectomy is surgery to remove a breast or part of a breast. It is usually done to treat breast cancer. Types of breast surgery include. Total (simple) mastectomy - removal of breast tissue and nipple.
Z90.12 is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.
Z85.3 is a billable ICD code used to specify a diagnosis of personal history of malignant neoplasm of breast. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
DRG Group #826-830 - Myeloprolif disord or poorly differentiated neoplasms with other operating room procedure without CC or MCC.
Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. The Center for Medicare & Medicaid Services (CMS) requires medical coders to indicate whether or not a condition was present at the time of admission, in order to properly assign MS-DRG codes.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been excised but further treatment, such as an additional surgery for the malignancy, radiation therapy or chemotherapy is directed to that site, the primary malignancy code should be used until treatment is completed.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
The neoplasm table in the Alphabetic Index should be referenced first. However, if the histological term is documented, that term should be referenced first, rather than going immediately to the Neoplasm Table, in order to determine which column in the Neoplasm Table is appropriate. Alphabetic Index to review the entries under this term and the instructional note to “see also neoplasm, by site, benign.” The table provides the proper code based on the type of neoplasm and the site. It is important to select the proper column in the table that corresponds to the type of neoplasm. The Tabular List should then be referenced to verify that the correct code has been selected from the table and that a more specific site code does not exist.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
When the reason for admission/encounter is to determine the extent of the malignancy, or for a procedure such as paracentesis or thoracentesis, the primary malignancy or appropriate metastatic site is designated as the principal or first-listed diagnosis, even though chemotherapy or radiotherapy is administered.
Z42.1 is a valid billable ICD-10 diagnosis code for Encounter for breast reconstruction following mastectomy . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
Z42.1 is exempt from POA reporting ( Present On Admission).
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also: